Compare StocksNTRS vs PFE

Northern Trust Corporation (NTRS) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-19, NTRS is fairly valued at $172, with a DCF intrinsic value of $196 and a margin of safety of 12%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, NTRS has the wider margin of safety.

NTRS
Northern Trust Corporation
$172.11
VS
PFE
Pfizer Inc.
$25.21

Rewards

NTRS
  • Free cash flow has grown at a 41.8% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Share count has been reduced by 11% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • Each dollar of retained earnings has created $1.54 of earning power — management is creating shareholder value.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

NTRS
  • Gross margin of 0.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Trailing P/E of 18.0x is 27% above the historical average of 14.2x — the stock trades at a premium to its own history.
  • Altman Z-Score of 0.27 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
NTRS
PFE
Valuation
N/A
Free Cash Flow
$12.38B
N/A
FCF Yield
8.61%
18.02
Trailing P/E
19.24
14.50
Forward P/E
8.91
Quality & Moat
12.04%
ROIC
10.19%
14.46%
ROE
8.31%
0.00%
Gross Margin
74.80%
1.37
PEG Ratio
13.77
Balance Sheet Safety
N/A
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
2.03
1.83%
Dividend Yield
6.61%
NTRS: 4Ties: 1PFE: 3
NTRSPFE

Historical Fundamentals

Learn more →
NTRS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
NTRS
$2.39
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$2.93B
Δ Market Cap
+$7.01B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
NTRS
12.3% Margin of Safety
Price is 12.3% below estimated fair value
Current Price: $172.11
Fair Value: $196.33
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
NTRS

Requires positive FCF to compute implied growth rate.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
NTRS
54/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
NTRS
-2.59
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
NTRS
Insiders 0.9%Institutions 86.5%Retail & Other 12.7%
No. of Institutional Holders1,300
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,744
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
NTRS
1
Buys (3M)
6
Buys (12M)
Total value (12M): $790,362
MORITZ ROBERT EDWARD JR.
Director
$37,442
@ $166.41 · 2026-05-01
PETRINO RICHARD
Director
$148,910
@ $148.91 · 2026-02-05
MORITZ ROBERT EDWARD JR.
Director
$37,203
@ $151.85 · 2026-02-02
MORITZ ROBERT EDWARD JR.
Director
$500,266
@ $128.57 · 2025-11-04
MORITZ ROBERT EDWARD JR.
Director
$34,198
@ $126.66 · 2025-10-27
MORITZ ROBERT EDWARD JR.
Director
$32,343
@ $126.34 · 2025-08-13
MORITZ ROBERT EDWARD JR.
Director
$10,261
@ $91.62 · 2025-04-24
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
NTRS
2
Sells (3M)
9
Sells (12M)
Total value (12M): $7.24M
HALLINAN AENGUS
Officer
$613,880
@ $167.36 · 2026-06-03
BELLOWS CLIVE
Officer
$462,056
@ $165.02 · 2026-04-24
FOX DAVID W JR
Chief Financial Officer
$468,362
@ $143.89 · 2026-03-04
FOX DAVID W JR
Chief Financial Officer
$208,872
@ $144.05 · 2026-02-25
BELLOWS CLIVE
Officer
$166,758
@ $145.26 · 2026-02-12
SOUTH THOMAS A
Officer
$695,150
@ $139.03 · 2025-12-11
LANDERS JOHN P.
Officer
$95,252
@ $124.35 · 2025-11-17
LEVY SUSAN COHEN
General Counsel
$3.54M
@ $128.13 · 2025-11-04
PARKER TERESA A
Officer
$997,458
@ $131.21 · 2025-07-31
HALLINAN AENGUS
Officer
$528.00
@ $105.60 · 2025-05-22
CONWAY KELLEY
Officer
$52,640
@ $105.28 · 2025-05-12
FOX DAVID W JR
Chief Financial Officer
$535,772
@ $105.55 · 2025-05-12
PARKER TERESA A
Officer
$650,710
@ $100.62 · 2025-05-09
BELLOWS CLIVE
Officer
$329,835
@ $99.95 · 2025-05-08
SOUTH THOMAS A
Officer
$429,852
@ $113.00 · 2025-02-19
LANDERS JOHN P.
Officer
$100,296
@ $111.44 · 2025-02-04
KARPINSKI JANE B.
Officer
$251,828
@ $111.33 · 2025-02-03
TYLER JASON J
Officer
$252,043
@ $112.67 · 2025-01-30
CHERECWICH PETER B
Chief Operating Officer
$2.94M
@ $112.36 · 2025-01-29
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
NTRS
FearGreed
😏Greed(68/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
NTRS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View NTRS Full AnalysisView PFE Full Analysis

Frequently Asked Questions: NTRS vs PFE

Is Northern Trust Corporation or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, NTRS trades at a 12.3% margin of safety (intrinsic value $196 vs. price $172), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Northern Trust Corporation or Pfizer Inc.?

NTRS scores 54/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Northern Trust Corporation in financial distress?

NTRS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 2.1 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Northern Trust Corporation or Pfizer Inc.?

NTRS earns 12.0% ROIC versus PFE's 10.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Northern Trust Corporation's or Pfizer Inc.'s?

NTRS's dividend earns a safety score of 91/100 (Very Safe), compared to PFE's 24/100 (Unsafe). NTRS has raised its dividend for 2 consecutive years.